Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
PETER RUTHERFORD
Peter Rutherford is Global Medical Lead for Renal Rare Disease at Vifor Pharma in Zurich, CH. He qualified in Medicine at the University of Newcastle upon Tyne, UK and completed postgraduate medical training to obtain MRCP in 1989. He entered an academic training pathway in Nephrology with an MRC Training Fellowship allowing him to complete a PhD in cell physiology as well as completing clinical training in Nephrology and Internal Medicine. He was then an MRC Travelling Fellow at Yale University School of Medicine gaining additional academic experience in molecular biology.
After return to the UK as Lecturer in Medicine at the Unversity of Newcastle, he was appointed as Senior Lecturer in Nephrology at the University of Wales College of Medicine and Consultant Nephrologist. In this role, he combined clinical practice in delivering a full range of nephrology services with academic work. Peter then developed expertise as a clinical leader in the hospital and became the Medical Director of a combined acute, community and mental health NHS organization leading on patient safety, clinical effectiveness, service improvement and research. In addition he was a Clinical advisor at NICE and chaired their Guidelines Review Panel until he joined Pharma in 2007.
From 2007 to 2015 he was Medical Director Renal for Europe, Middle East and Africa at Baxter Healthcare – being responsible for all aspects of Medical Affairs activities across the region. He worked on research projects in patient support, decision making and education as well as new product development for home dialysis. From 2015 to 2017 he was Head of Integrated Market Access at Quintiles in Europe and Emerging Markets – supporting small and large Pharma and emerging biotech companies with medical affairs, medical communications, market access and patient centric services. Focused on launch brands, Peter support a range of companies across a range of therapeutic areas. Since joining Vifor Pharma, he is back on home ground in Nephrology but working in systemic diseases affecting every organ system.
OGÃœN SAZOVA
Dr. Ogün Sazova has graduated Istanbul University Faculty of Medicine and has a specialization degree for family medicine. After spending 5 years in clinical and research setting in Turkey and Germany, he joined pharmaceutical industry in 2003 and worked in local medical and commercial roles before joining AstraZeneca (AZ) Turkey as the Head of Primary Care Medical Affairs. In this role, Ogün has built the MSL function in AZ Turkey amongst other medical affairs deliverables.
In 2009, Ogün moved to EU regional organization in Brussels and was the EU Medical Affairs Director for Cardiovascular Diseases for AZ. In 2012, he was appointed as the Global Nominated Signatory Practice Director in Global Medical Excellence group, and moved to London with his family. In this role, Ogün has set standards for Nominated Signatory operations worldwide, including risk & control framework, training, accreditation, and many examples of simplification. After this role, Ogün has taken over the lead of the Global Medical Academy and established it as a centre of excellence in AZ to drive world-class scientific engagements by medical teams in the countries. In his final role with AZ, Ogün worked in Rheumatology & Inflammation therapy area and moved to Napp Pharmaceuticals in January 2020, where he is currently working as the Country Medical Director for the UK & Ireland.
Damian Largier
Damian Largier is a South African born physician who completed a Masters in Obstetrics and Gynecology at the University of Cape Town with a focus on Developmental Endocrinology. After five years in clinical practice he joined the pharmaceutical industry initially with Glaxo Wellcome and then as Country Medical Director for Pfizer in South Africa.
He has held leadership positions for Pfizer Medical Affairs in Europe and the United States as well as at a Global level with a particular focus on medical communications and late stage product development. He is now the Vice President Medical Affairs for the International Developed Markets (Europe, Japan and Developed Asia) for Internal Medicine.
THÉRÈSE MCCALL
[vc_row][vc_column][vc_custom_heading text=”VP, Medical Affairs” el_class=”leader_inner_heading”][vc_custom_heading text=”Assertio Therapeutics, Inc” el_class=”leader_inner_heading-2″][vc_column_text el_class=”leader_content”]Dr. Thérèse McCall is presently Vice President of Medical Affairs at Assertio Therapeutics, Inc, Lake Forest, IL. She received a doctorate in clinical medicine from Trinity College in Dublin, Ireland, and a master’s degree in business administration from Northwestern University in Evanston, IL. She also holds a diploma in print journalism and radio broadcasting.
Dr. McCall has over 30 years of leadership experience with global companies in the fields of drug discovery, research and product commercialization strategy, clinical development, and regulatory approval. She has deep expertise in external stakeholder engagement and is focused on global medical affairs innovation, product commercialization, and medical communications transformation. During her career, Dr. McCall has consistently developed innovative medical and commercial strategies and solutions. She has led US and global initiatives involving external thought leader and reimbursement decision makers, investigator research programs, publications, medical information, and regulatory and compliance activities. Her therapeutic expertise includes oncology, immunology, gastroenterology, cardiology, neuroscience, and diabetes.
Dr. McCall has a long-standing interest in advancing the public’s understanding of science. To this end, she has developed and presented radio interviews and school presentations, and she has worked as a London-based science correspondent for the BBC. In addition, Dr. McCall has authored over 30 scientific publications, including newspaper and book chapters.[/vc_column_text][/vc_column][/vc_row]